Carcinoid Syndrome

Also known as: Malignant Carcinoid Syndrome / Carcinoid syndrome (disorder)

DrugDrug NameDrug Description
DB06791LanreotideA somatostatin analog used for the treatment of unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors and acromegaly.